drug
siponimod fumarate
Marketedupdated 2mo agoby $NVS NOVARTIS AG
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying siponimod fumarate
Patent cliff
source: FDA Orange Bookfirst barrier falls
Aug 27, 2028
~2.1 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (15)
- Apr 23, 2036method-of-use (U-3889)US 11944602
- Apr 23, 2036method-of-use (U-3889)US 11944602
- Apr 23, 2036method-of-use (U-3889)US 11944602
- Apr 23, 2036method-of-use (U-4407)US 12533340
- Apr 23, 2036method-of-use (U-4407)US 12533340
- Apr 23, 2036method-of-use (U-4407)US 12533340
- Jan 5, 2032formulationUS 12071402
- Jan 5, 2032formulationUS 12071402
- Jan 5, 2032formulationUS 12071402
- Nov 30, 2030method-of-use (U-2511)US 84924414.4y
- Nov 30, 2030method-of-use (U-2511)US 84924414.4y
- Nov 30, 2030method-of-use (U-2511)US 84924414.4y
- Aug 27, 2028compositionUS 79395192.1y
- Aug 27, 2028compositionUS 79395192.1y
- Aug 27, 2028compositionUS 79395192.1y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 3m ago
Found something off?
comments(0)
5-min edit window · permanent after that